US Stock MarketDetailed Quotes
RVPH Reviva Pharmaceuticals
- 1.120
- -0.030-2.61%
Close Nov 26 16:00 ET
- 1.160
- +0.040+3.56%
Post 16:37 ET
37.45MMarket Cap-1037P/E (TTM)
1.160High1.085Low444.39KVolume1.150Open1.150Pre Close497.37KTurnover1.92%Turnover RatioLossP/E (Static)33.44MShares5.67052wk High-3.76P/B25.87MFloat Cap0.60052wk Low--Dividend TTM23.10MShs Float15.100Historical High--Div YieldTTM6.52%Amplitude0.530Historical Low1.119Avg Price1Lot Size
About Reviva Pharmaceuticals Company
Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the central nervous system, respiratory, and metabolic diseases. It uses chemical genomics driven technology platform and proprietary chemistry to develop new medicines. It focuses on the RP5063 (Brilaroxazine) and RP1208 pipelines. The company was founded by Laxminarayan Bhat on December 11, 2020 and is headquartered in Cupertino, CA.
Company Profile
SymbolRVPH
Company NameReviva Pharmaceuticals
Listing DateOct 18, 2018
Founded2020
CEODr. Laxminarayan Bhat, PhD
MarketNASDAQ
Employees15
Fiscal Year Ends12-31
Address10080 North Wolfe Road,Suite SW3-200
CityCupertino
ProvinceCalifornia
CountryUnited States of America
Zip Code95014
Phone1-408-501-8881
Websitehttp://www.revivapharma.com
Company Executives
- Name
- Position
- Salary
- Dr. Laxminarayan Bhat, PhD
- Director, President and Chief Executive Officer
- 2.76M
- Narayan Prabhu
- Chief Financial Officer and Principal Accounting Officer
- 1.25M
- Parag Saxena
- Chairman of the Board
- 107.01K
- Purav Patel
- Independent Director
- 90.51K
- Les Funtleyder
- Independent Director
- 88.01K
- Dr. Richard Margolin, M.D.
- Independent Director
- 81.76K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data